Inovio Pharmaceuticals Inc (INO)
9.605
-0.60
(-5.83%)
USD |
NASDAQ |
Apr 19, 15:36
Inovio Pharmaceuticals Cash and Short Term Investments (Quarterly): 145.29M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 145.29M |
September 30, 2023 | 167.47M |
June 30, 2023 | 194.93M |
March 31, 2023 | 223.75M |
December 31, 2022 | 253.00M |
September 30, 2022 | 281.88M |
June 30, 2022 | 348.13M |
March 31, 2022 | 360.39M |
December 31, 2021 | 401.31M |
September 30, 2021 | 394.94M |
June 30, 2021 | 443.68M |
March 31, 2021 | 518.60M |
December 31, 2020 | 411.64M |
September 30, 2020 | 337.24M |
June 30, 2020 | 371.66M |
March 31, 2020 | 270.00M |
December 31, 2019 | 89.53M |
September 30, 2019 | 93.80M |
June 30, 2019 | 105.97M |
March 31, 2019 | 128.00M |
December 31, 2018 | 81.23M |
September 30, 2018 | 85.49M |
June 30, 2018 | 95.60M |
March 31, 2018 | 112.77M |
December 31, 2017 | 127.43M |
Date | Value |
---|---|
September 30, 2017 | 141.89M |
June 30, 2017 | 92.00M |
March 31, 2017 | 89.66M |
December 31, 2016 | 104.77M |
September 30, 2016 | 119.69M |
June 30, 2016 | 134.53M |
March 31, 2016 | 146.79M |
December 31, 2015 | 162.99M |
September 30, 2015 | 170.78M |
June 30, 2015 | 154.59M |
March 31, 2015 | 81.01M |
December 31, 2014 | 93.62M |
September 30, 2014 | 100.93M |
June 30, 2014 | 108.86M |
March 31, 2014 | 116.78M |
December 31, 2013 | 52.63M |
September 30, 2013 | 46.17M |
June 30, 2013 | 23.46M |
March 31, 2013 | 28.07M |
December 31, 2012 | 13.68M |
September 30, 2012 | 15.14M |
June 30, 2012 | 19.44M |
March 31, 2012 | 24.86M |
December 31, 2011 | 30.21M |
September 30, 2011 | 31.07M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
89.53M
Minimum
Dec 2019
518.60M
Maximum
Mar 2021
284.91M
Average
281.88M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
Cerus Corp | 65.85M |
Stereotaxis Inc | 19.82M |
Viemed Healthcare Inc | 12.84M |
AIM ImmunoTech Inc | 13.07M |
Protalix BioTherapeutics Inc | 44.56M |